Umbilical Cord Transplantation for the Elderly Population

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

November 21, 2018

Study Completion Date

November 21, 2018

Conditions
Hematologic Malignancies
Interventions
BIOLOGICAL

StemEx

"For patients allocated to StemEx® arm:~* Day -20: Start small (or equal) portion expansion at processing site. (II) Conditioning Phase~* Day -6 to -1: Subject receives a RIC regimen containing Fludarabine, Cyclophosphamide and Total Body Irradiation (TBI) (III) Transplantation and Follow-up Phase~* Day 0: CBU unmanipulated portion transplantation (for StemEx® arm) or unmanipulated CBU transplantation.~* Day 1: StemEx® transplantation.~* Day 2 to 3 years: Post transplant follow-up."

Trial Locations (1)

60153

Loyola University Medical Center, Maywood

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Gamida Cell ltd

INDUSTRY

lead

Loyola University

OTHER